NCT00751738 · Interventional trial
Long Term Safety of 125 mg Per Day of Oral Azimilide in Patients With Implantable Cardioverter Defibrillator (ICDs)
Overall registry status Completed
Phase 3
Conditions Arrhythmias
Delaware Valley sites
- Research Facility · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory